| Aug 21 |
PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy
|
| Aug 14 |
3 Robotics Stocks to Sell in August Before They Crash & Burn
|
| Aug 4 |
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
|
| Aug 4 |
PROCEPT BioRobotics Corporation (PRCT) Q2 2024 Earnings Call Transcript
|
| Aug 3 |
PROCEPT BioRobotics Second Quarter 2024 Earnings: Beats Expectations
|
| Aug 1 |
PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 1 |
Procept GAAP EPS of -$0.50 beats by $0.02, revenue of $53.3M beats by $3.08M
|
| Aug 1 |
PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance
|
| Jul 31 |
Procept Q2 2024 Earnings Preview
|
| Jul 24 |
With 84% ownership of the shares, PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is heavily dominated by institutional owners
|
